As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

Marks the first jurisdictional issuance of an international patent for a family of novel small molecule compoundsPatent ...

A study by Washington University School of Medicine and the VA St. Louis Health Care System has found that GLP-1 drugs can ...

GLP-1RA weight-loss drugs provide health benefits but also pose risks, including pancreatitis, kidney problems, and ...

RELATED: Doctor Says Ozempic Raises Certain Health Risks by Up to 900%. Per the study, weight-loss drugs can lower the risk for 42 health conditions, while also raising someone’s risk of developing 19 ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Learn more about a new study claiming that GLP-1s could be used to treat cognitive conditions like dementia, but may pose a ...

Microglia, the brain’s immune cells, play vital roles in clearing toxins and maintaining neuronal health but can also ...

The implications of this research could redefine the boundary between life and death, help people on the cusp of death, and ...

Pauline Quirke's shock dementia diagnosis has caused an increase in concerns about the disease and its symptoms. Impacting ...

A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.